Analyst Ratings for Solid Biosciences (SLDB)
SLDB Rating Summary
SLDB Price Target Summary
- Highest: $26.00 (Guggenheim)
- Lowest: $9.00 (Barclays)
- Average: $16.55
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$16.55 (+98.6%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$16.55 (+98.6%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/20/2026 | Guggenheim | Debjit Chattopadhyay | New Coverage | Buy (N/A) |
26.00 (N/A) |
7.12 (8.33) |
16.99% | Details |
| 12/4/2025 | Needham | Gil Blum | New Coverage | Buy (N/A) |
16.00 (N/A) |
5.19 (8.33) |
60.5% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
